DALLA COSTA, GLORIA
 Distribuzione geografica
Continente #
EU - Europa 299
NA - Nord America 180
AS - Asia 32
OC - Oceania 1
Totale 512
Nazione #
SE - Svezia 211
US - Stati Uniti d'America 179
IT - Italia 26
FI - Finlandia 23
IE - Irlanda 23
CN - Cina 19
DE - Germania 7
GB - Regno Unito 6
SG - Singapore 6
IR - Iran 3
IN - India 2
AU - Australia 1
CA - Canada 1
FR - Francia 1
IL - Israele 1
NL - Olanda 1
PK - Pakistan 1
RO - Romania 1
Totale 512
Città #
Lawrence 46
Princeton 46
Dublin 23
Helsinki 22
Shanghai 19
Ashburn 14
Milan 13
New York 10
Bergamo 3
Manchester 3
Kish 2
Assisi 1
Bengaluru 1
Bran 1
Figtree 1
Gunzenhausen 1
Karachi 1
Lappeenranta 1
Mountain View 1
Pune 1
Seattle 1
Singapore 1
Tel Aviv 1
Zanjan 1
Totale 214
Nome #
The Danger of Walking with Socks: Evidence from Kinematic Analysis in People with Progressive Multiple Sclerosis 18
Repetitive Transcranial Magnetic Stimulation With H-Coil in Alzheimer's Disease: A Double-Blind, Placebo-Controlled Pilot Study 18
Dysregulation of MS risk genes and pathways at distinct stages of disease 16
Assessing the role of innovative therapeutic paradigm on multiple sclerosis treatment response 16
Fifteen years of wireless sensors for balance assessment in neurological disorders 16
LETTER RE: The contemporary spectrum of multiple sclerosis misdiagnosis: A multicenter study 15
High frequency of intestinal TH17 cells correlates with microbiota alterations and disease activity in multiple sclerosis 15
Loss of circulating CD8+ CD161high T cells in primary progressive multiple sclerosis 15
From neuroimaging to clinical setting: What have we learned from migraine pain? 15
Assessing seasonal dynamics of Guillain-Barré syndrome with search engine query data 15
Walking-related digital mobility outcomes as clinical trial endpoint measures: Protocol for a scoping review 15
MiR-125a-3p timely inhibits oligodendroglial maturation and is pathologically up-regulated in human multiple sclerosis 15
Refractory migraine: the role of the physician in assessment and treatment of a problematic disease 15
Conversion from clinically isolated syndrome to multiple sclerosis: A large multicantre study 14
Neutrophil-to-lymphocyte ratio: a marker of neuro-inflammation in multiple sclerosis? 14
Basal vitamin D levels and disease activity in multiple sclerosis patients treated with fingolimod 13
Free Light Chains and Intrathecal B Cells Activity in Multiple Sclerosis: A Prospective Study and Meta-Analysis 13
CSF extracellular vesicles and risk of disease activity after a first demyelinating event 13
Overcoming recruitment challenges in patients with multiple sclerosis: Results from an Italian survey. 12
Clinical significance of the number of oligoclonal bands in patients with clinically isolated syndromes. 12
Disease-modifying treatments modulate myeloid cells in multiple sclerosis patients 12
Caesarean section and infant formula feeding are associated with an earlier age of onset of multiple sclerosis 12
Using smartphones and wearable devices to monitor behavioral changes during COVID-19 12
Bilateral Repetitive Transcranial Magnetic Stimulation With the H-Coil in Parkinson's Disease: A Randomized, Sham-Controlled Study 12
Recurrent disease-activity rebound in a patient with multiple sclerosis after natalizumab discontinuations for pregnancy planning. 11
Vitamin D levels and risk of developing multiple sclerosis 11
Migralepsy: a new case confirming the existence of this migraine complication and proposing therapy 11
The Communication of Multiple Sclerosis Diagnosis: The Patients' Perspective 11
Serum neurofilament light chain levels are increased in patients with a clinically isolated syndrome 11
Intracortical motor conduction is associated with hand dexterity in progressive multiple sclerosis 11
Digital epidemiology confirms a latitude gradient of MS in France 11
Vitamin D levels and risk of multiple sclerosis in patients with clinically isolated syndrome 10
Parry Romberg Syndrome associated with chronic facial pain. 10
Performance of the 2017 and 2010 Revised McDonald Criteria in Predicting MS Diagnosis After a Clinically Isolated Syndrome: A MAGNIMS Study 10
Opinion & special articles: professionalism in neurology. Maintaining patient rapport in a world of EMR. 9
Prognostic Value of Vitamin D in Clinically Isolated Syndromes (CIS) 9
Serum neurofilaments increase at progressive multifocal leukoencephalopathy onset in natalizumab-treated multiple sclerosis patients 9
Platelet glutamate uptake and Th1 cells inversely correlate in relapsing/remitting and in progressive multiple sclerosis 9
Real-time assessment of COVID-19 prevalence among multiple sclerosis patients: a multicenter European study 9
Subclinical anterior optic pathway involvement in early multiple sclerosis and clinically isolated syndromes 9
Progressive ataxia in a natalizumab-treated multiple sclerosis patient: the dark side of JC virus infection. 8
Smart watch, smarter EDSS: Improving disability assessment in multiple sclerosis clinical practice 8
Severe disease activity in a patient with multiple sclerosis after daclizumab discontinuation 8
Reply to “Serum Neurofilaments as Candidate Biomarkers of Natalizumab Progressive Multifocal Leukoencephalopathy” 8
Prognostic value of serum neurofilaments in patients with clinically isolated syndromes 6
Multiple biomarkers improve the prediction of multiple sclerosis in clinically isolated syndromes 5
null 1
null 1
null 1
null 1
Totale 551
Categoria #
all - tutte 7.909
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.909


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202016 0 0 0 0 0 0 0 0 0 16 0 0
2020/20219 0 0 0 4 3 0 1 0 0 0 1 0
2021/202264 0 0 0 30 2 3 5 4 5 0 0 15
2022/2023331 115 84 27 0 0 38 23 30 13 0 1 0
2023/2024111 0 2 29 18 19 14 5 18 1 5 0 0
Totale 551